A cross sectional sero-prevalence study was conducted on 1,595 cattle in Jimma zone, Ethiopia to investigate the status of bovine brucellosis and identify potential risk factors. Sera samples were analyzed using Rose Bengal Plate Test (RBPT) and Complement Fixation Test (CFT). The overall individual and herd level sero-prevalences were 3.1% (n = 1,595) and 15.0% (n = 227), respectively. The sero-prevalence of bovine brucellosis at individual animal level was significantly higher in non-pregnant (11.18%) than pregnant (2.77%) and lactating (22.35%) than non-lactating animals (2.46%). Moreover, significantly higher sero-prevalence was observed in herds of larger sizes. Individual animal sero-prevalence was also positively associated with the occurrence of abortion (26.98 and 1.54% in those with and without previous history of abortion, respectively). Generally, the sero-prevalence of bovine brucellosis found in Jimma area was not high and the sero-prevalence was closely associated with some of the risk factors considered at individual animal and herd level.
A study was conducted to determine the prevalence of mastitis, identify the major bacterial pathogens and test the antimicrobial resistance of milk bacterial isolates in smallholder dairy farms in Selalle area, Ethiopia. A total of 109 smallholder dairy farms comprising 500 crossbred lactating cows were included. The prevalence of clinical mastitis at herd, cow and quarter level was 8.3% (n=9), 1.8% (n=9) and 0.51% (n=10), respectively, while that of sub-clinical mastitis was 54.7%, 22.3% and 10.1%, respectively. The univariate logistic regression showed that among the risk factors considered, presence of teat lesion, stage of lactation and parity number had significant effect on the prevalence of sub-clinical mastitis. However, after multivariate analysis, only presence of teat lesion and stage of lactation had significant effect. The common isolates from the clinical mastitic quarters were St. agalactiae (30%, n=3) and St. dysgalactiae (30%, n=3), while from sub-clinical cases were S. aureus (42.6%, n=83), S. epidermidis (22.1%, n=43), St. agalactiae (12.8%, n=25) and St. uberis (10.3%, n=20). Staphylococcus intermedius and Streptococcus dysgalactiae were the species, which showed high level of susceptibility for most of the antimicrobials tested, while the remaining had varying levels of resistance for almost all the antimicrobials used. Among the antimicrobials employed, erythromycin and sulphonamide showed the lowest proportion of resistant isolates. Considering the possible significant economic losses that could be incurred by both clinical and sub-clinical mastitis, attention should be paid for further detailed investigations including the economic losses and benefits of interventions in the study area.
A cross sectional study was carried out to assess the prevalence, economic and public health significance of echinococcosis/hydatidosis in Tigray Regional State, north Ethiopia. Out of 18 stray dogs euthanized and examined, three of them were found harboring the adult parasite Echinococcus granulosus in their small intestine. From 5,194 cattle examined at slaughter houses, 1146 (22.1%) of them were found harboring hydatid cyst. The majority of the infected cattle had hydatid cyst in both liver and lungs. The hydatid cyst infection in the lung, liver, kidney, heart and spleen were found to be 13%, 8.1%, 0.5%, 0.4%, and 0.1%, respectively. The estimated total annual loss from bovine hydatidosis due to offal condemnation (lungs and liver) and carcass weight loss was 25,608 Ethiopian (Eth.) Birr. The present human hydatidosis survey conducted in all six zonal hospitals of Tigray Regional State disclosed one active clinical case in Mekelle hospital during the study period. While, the retrospective data analyses of the six zonal hospitals indicated that eight cases of human hydatidosis were diagnosed since 2000. Thus echinococcosis/hydatidosis is considerably prevalent disease in cattle and it is a serious public health concern in Tigray region.
A study was conducted to assess the reproductive performance and factors that influence reproductive efficiency of cows in smallholder dairy farms in Selalle, Central Ethiopia. Three hundred dairy farms (average herd size = 8) were visited and data on reproductive, breeding and management histories were collected and analysed. The overall geometric means for calving to conception interval (n=382) and duration after last calving (n=422) were 187 and 201 days in pregnant and non-pregnant cows, respectively. The least-squares mean calving to conception interval was higher (p < 0.05) in mixed crop-livestock production (MCLP) than in small urban dairy production (SUDP) systems and was lower (p < 0.01) in non-suckling than in suckling cows. District significantly influenced (p < 0.01) the least-squares mean duration after last calving and, among the districts, non-pregnant cows in Wuchale-Jida had the highest values, whereas cows in Sululta and Mulo had the lowest values. The overall average number of services per conception (+/-SD) and the first service conception rate were 1.6 +/- 1.0 (n=382) and 56% (n=456), respectively. The prevalences of abortion, dystocia (assisted parturition), retained fetal membrane, vulval discharge/endometritis and pre-weaning calf mortality were 1.4%, 1.3%, 5.4%, 2.8% and 17.4%, respectively. The present estimates of extended calving to conception interval and duration after last calving indicate poor reproductive performances of cows in Selalle smallholder dairy farms. The pre-weaning calf mortality rate is highly significant. Accordingly, a further detailed investigation is necessary to identify and quantify the specific reproductive disorders and associated interacting factors attributing to such poor performance and to determine the causes and predisposing factors behind such high calf mortality.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.